Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (vol 32, pg 345, 2019)

Authors :: Pfeifer, H.
Cazzaniga, G.
Velden, V.H.J. van der
Cayuela, J.M.
Schafer, B.
Spinelli, O.
Akiki, S.
Avigad, S.
Bendit, I.
Borg, K.
Cave, H.
Elia, L.
Reshmi, S.C.
Gerrard, G.
Hayette, S.
Hermanson, M.
Juh, A.
Jurcek, T.
Chillon, M.C.
Homburg, C.
Martinelli, G.
Kairisto, V.
Lange, T.
Lion, T.
Mueller, M.C.
Pane, F.
Rai, L.
Damm-Welk, C.
Sacha, T.
Schnittger, S.
Touloumenidou, T.
Valerhaugen, H.
Vandenberghe, P.
Zuna, J.
Serve, H.
Herrmann, E.
Markovic, S.
Dongen, J.J.M. van
Ottmann, O.G.
Publication Year :: 2020
Publisher :: NATURE PUBLISHING GROUP, 2020.
Abstract: An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Tools